Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

Resmed (NYSE:RMD) and Oura announced a partnership to expand access to sleep health education and care pathways for Oura Ring members in the U.S.

Oura Ring Gen3 and Ring 4 users with active memberships can access Resmed educational tools, sleep assessments, and options to connect with independent healthcare providers.

Argus May 19 session

+1.78% close to close Open Argus

Details

News Market Reaction – RMD

On May 19, the day this news came out, RMD closed 1.78% above the previous close.

Data tracked by StockTitan Argus for the May 19 session.

Key Figures

Wearable use 2015: 16% of adults Wearable use 2026: 53% of adults Undiagnosed OSA: 80% undiagnosed +5 more

Wearable use 2015: 16% of adults; Adults using wearable technology to track sleep in 2015
Wearable use 2026: 53% of adults; Adults using wearable technology to track sleep in 2026
Undiagnosed OSA: 80% undiagnosed; Estimated share of U.S. obstructive sleep apnea cases undiagnosed
Current price: $204.15; RMD share price before this partnership news
52-week high: $293.81; RMD 52-week high level
52-week low: $198.61; RMD 52-week low level
Daily move: 1.12%; Price change over the last 24 hours pre-news
Oura devices covered: Gen3 and Ring 4; Experience available to Oura Ring Gen3 and Oura Ring 4 users

Historical Context

5 past events · Latest: Apr 30

5 events

Apr 30
CFO transition

24h Move

-4.1%

CFO retirement and succession plan with outlook reiterated.
Apr 30
Quarterly earnings

24h Move

-4.1%

Q3 FY2026 revenue, margin and EPS growth update.
Apr 01
Earnings schedule

24h Move

+0.6%

Announcement of date and webcast for Q3 FY2026 results.
Mar 03
Sleep survey data

24h Move

+0.3%

Global sleep survey highlighting awareness and behavior gaps.
Feb 24
U.S. expansion

24h Move

-3.5%

New Greenwood distribution center to expand logistics capacity.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

obstructive sleep apnea

1 terms

obstructive sleep apnea medical

"to learn more about potential sleep disorders, including obstructive sleep apnea (OSA)."

Obstructive sleep apnea is a common medical condition where the throat repeatedly narrows or closes during sleep, causing short pauses in breathing, drops in blood oxygen and fragmented rest. It matters to investors because it creates ongoing demand for medical devices, diagnostics, treatments and sleep-monitoring services, and it can affect population health, workforce productivity and healthcare spending—like a recurring leak in a system that requires continual repair and monitoring.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

05/19/2026 - 09:00 AM

Oura Members can take action on changes in sleep or breathing patterns through educational resources from Resmed and pathways for accessing care

SAN DIEGO, May 19, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, and ŌURA, maker of the world’s leading smart ring, today announced they are partnering to expand access to sleep health education and pathways to care, helping more people sleep better and improve their overall health.

Sleep is increasingly recognized as a key pillar of long-term health, yet it remains widely underprioritized.¹ Early signs of poor sleep are often dismissed, creating a gap between what people experience and when they seek support or clinical care.

At the same time, the use of wearable technology to track sleep is on the rise, increasing from 16% of adults in 2025² to 53% in 2026.³ Insights from wearable devices, including Oura Ring, can help people better understand their sleep patterns and encourage them to have informed conversations with their healthcare providers to learn more about potential sleep disorders, including obstructive sleep apnea (OSA). OSA is a chronic condition that disrupts breathing during sleep and often goes undiagnosed. In the U.S., an estimated 80% of people with OSA remain undiagnosed and untreated.⁴ Resmed and Oura are partnering to help close the awareness gap, turning insight into action.

Oura Members who experience a higher number of nighttime breathing disturbances can easily connect to trusted resources from Resmed, including:

Educational resources and a sleep assessment to understand more about sleep health.
The option to connect with an independent healthcare provider, virtually or in-person, to address their sleep concerns.
An informative guide to support discussions with their healthcare provider.

By connecting consumer-generated wellness insights with Resmed’s sleep health resources, Resmed and Oura are helping Oura Members take a more informed next step to better understand their sleep health.

"We're at an inflection point in how people engage with their sleep health, driven by rising awareness and more accessible technology," said Dr. Carlos Nunez, chief medical officer at Resmed. "By partnering with ŌURA, we are turning insight into action by guiding people across their sleep health journey and making it easier for them to seek clinical evaluation and care if they have concerns about their sleep.”

“High-quality sleep is one of the strongest foundations for long-term health, yet many people live for years with unrecognized sleep and breathing issues," said Dr. Ricky Bloomfield, chief medical officer at Oura. “By pairing Oura’s continuous insights into sleep and nighttime breathing with Resmed’s sleep expertise, we’re giving people clearer tools and education to spot when something might be off and to more easily access care so they can better understand and act on changes in their sleep health.”

Resmed’s connection with Oura is designed to reach individuals who may not recognize their sleep issues or engage with the healthcare system, making it easier for people to learn about their sleep health and connect with clinical resources when they need it. The experience is available to users of Oura Ring Gen3 and Oura Ring 4 who have an active Oura Membership in the U.S.

About Resmed

Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.

About ŌURA

ŌURA delivers personalized health data, insights, and daily guidance with Oura Ring, the leading smart ring that helps you live healthier, longer. Guided by a mission to shift healthcare from sick care to prevention, ŌURA supports millions of members worldwide across sleep, activity, stress, readiness, women’s health, and heart health. Scientifically validated against medical gold standards, the lightweight Oura Ring tracks 50+ health metrics continuously, empowering both individuals and thousands of research teams, healthcare providers, and organizations. With 1,000 ecosystem partners across wellness and medicine, ŌURA is advancing the future of preventative health.

Founded in Finland in 2013, ŌURA has U.S. headquarters in San Francisco and E.U. headquarters in Oulu. ŌURA was last valued at approximately $11B—making it the world’s most valuable standalone wearable company. Learn more at ouraring.com or connect with ŌURA on Instagram, LinkedIn, and TikTok.

Oura Ring is not a medical device and is not intended to diagnose, treat, cure, monitor, or prevent medical conditions or illnesses.

Contacts

Resmed

For Media	For Investors
Caela Shay	Salli Schwartz
Caela.shay@resmed.com	Salli.Schwartz@resmed.com
news@resmed.com	investorrelations@resmed.com

Oura
press@ouraring.com

¹ Resmed Global Sleep Survey 2026. Available at: sleepsurvey.resmed.com
² Resmed Global Sleep Survey 2025. Available at: sleepsurvey.resmed.com
³ Resmed Global Sleep Survey 2026. Available at: sleepsurvey.resmed.com
⁴ Kapur VK, Auckley DH, Chowdhuri S, et al. Clinical Practice. Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Resmed (NYSE:RMD) and Oura announce on May 19, 2026?

Resmed and Oura announced a partnership to expand access to sleep health education and care pathways for Oura Ring members. According to Resmed, users can access educational resources, sleep assessments, and options to connect with independent healthcare providers about sleep concerns.

How does the Resmed and Oura partnership help Oura Ring members with sleep issues?

The partnership provides Oura members experiencing increased nighttime breathing disturbances with direct access to Resmed sleep education and care options. According to Resmed, members can use assessments, guides, and links to independent healthcare providers to better understand and address possible sleep disorders.

Which Oura Ring users can access Resmed sleep resources through this collaboration?

Resmed’s connection with Oura is available to Oura Ring Gen3 and Oura Ring 4 users with an active Oura Membership in the U.S. According to Resmed, these members can access sleep education, assessments, and clinical resource pathways when needed.

How might the Resmed and Oura partnership address undiagnosed obstructive sleep apnea?

The partnership aims to guide people from wearable sleep insights to clinical evaluation for potential disorders like obstructive sleep apnea. According to Resmed, many individuals have undiagnosed OSA, and easier access to education and providers may encourage earlier discussions with clinicians.

What specific tools will Oura members receive from Resmed under this agreement?

Oura members can access educational resources, a sleep assessment, and an informative guide to support conversations with healthcare providers. According to Resmed, there is also an option to connect virtually or in person with independent healthcare professionals about sleep-related concerns.

Why are Resmed and Oura focusing on wearable data and sleep health education?

They are focusing on rising wearable use and the gap between sleep symptoms and seeking care. According to Resmed, continuous sleep and breathing insights from Oura, combined with expert resources, can help people recognize issues earlier and pursue appropriate clinical support.

Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care